EMEND INJECTION Rx

Select the drug indication to add to your list

EMEND INJECTION

Nausea
Only 4 drugs may be compared at once

Generic Name and Formulations:

Fosaprepitant dimeglumine (prodrug of aprepitant) 115mg/vial, 150mg/vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains polysorbate 80.

Select therapeutic use:

Indications for EMEND INJECTION:

In combination with other antiemetic agents to prevent acute and delayed nausea and vomiting associated with initial and repeat courses of moderately to highly emetogenic cancer chemotherapy, including high-dose cisplatin.

Adult:

≥18yrs: Give with corticosteroid and 5-HT3 antagonist (see full labeling). Administer approx. 30mins prior to chemotherapy. 150mg IV over 20–30mins on Day 1.

Children:

<18yrs: not established.

Contraindications:

Concomitant pimozide.

Warnings/Precautions:

Not for chronic continuous use. Severe hepatic impairment. Pregnancy. Nursing mothers.

Interactions:

See Contraindications. Monitor, and caution with, CYP3A4 substrates, including chemotherapy agents (eg, ifosfamide, vinblastine, vincristine). Avoid concomitant moderate-to-strong CYP3A4 inhibitors (eg, azole antifungals, macrolides, nefazodone, ritonavir, nelfinavir, diltiazem) or strong CYP3A4 inducers (eg, carbamazepine, phenytoin, rifampin). Potentiates dexamethasone (reduce its dose by 50%), methylprednisolone (reduce its IV dose by 25% and its oral dose by 50%), midazolam, alprazolam, triazolam. May antagonize warfarin (closely monitor INR for 2 weeks after starting each regimen), other CYP2C9 substrates, oral contraceptives (use alternative or backup method during and for 1 month after last dose).

See Also:

EMEND

EMEND for ORAL SUSPENSION

Pharmacological Class:

Substance P/NK1 receptor antagonist.

Adverse Reactions:

Fatigue, diarrhea, asthenia, dyspepsia, abdominal pain, hiccups, WBC count decreased, dehydration, ALT/AST increased, neutropenia, headache, anorexia, cough, hemoglobin decreased, dizziness, constipation, hypotension. Injection: inj site pain.

Generic Availability:

NO

How Supplied:

Caps 40mg—1, 5; 80mg, 125mg—6; Bi-fold pack (2 x 80mg)—1; Tri-fold pack (1 x 125mg + 2 x 80mg)—1; Susp kit—1 (w. oral dispensers, supplies); Vial—1